1. Acknowledgement to Referees

   Acknowledgement to Referees 25 November 2014 Pages: 1099 - 1102

2. Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date

   • Alexandra S. Potter
   • Geoffrey Schaubhut
   • Megan Shipman

   Leading Article 28 October 2014 Pages: 1103 - 1113

3. Methamphetamine Psychosis: Epidemiology and Management

   • Suzette Glasner-Edwards
   • Larissa J. Mooney

   Therapy in Practice 06 November 2014 Pages: 1115 - 1126

4. Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians

   • Riccardo Soffietti
   • Luca Bertero
   • Roberta Rudà

   Therapy in Practice 18 November 2014 Pages: 1127 - 1137

   

5. Drug-Induced Cerebellar Ataxia: A Systematic Review

   • J. van Gaalen
   • F. G. Kerstens
   • B. P. C. van de Warrenburg

   Systematic Review 13 November 2014 Pages: 1139 - 1153

6. Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease

   • Eva Schaeffer
   • Andrea Pilotto
   • Daniela Berg

   Review Article 24 October 2014 Pages: 1155 - 1184

   

7. A Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild–Moderate Alzheimer’s Disease

   • Michael H. Rosenbloom
   • Terry R. Barclay
   • Leah R. Hanson

   Short Communication 06 November 2014 Pages: 1185 - 1189

   

8. Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

   • Tobias Banaschewski
   • Mats Johnson
   • David R. Coghill

   Original Research Article Open access 20 August 2014 Pages: 1191 - 1203

   

9. Comment on: “Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence”

   • David R. Whitlock

   Letter to the Editor 06 November 2014 Pages: 1205 - 1206

10. Authors’ Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

    • Tracey A. Ignatowski
    • Robert N. Spengler
    • Edward Tobinick

    Letter to the Editor Open access 06 November 2014 Pages: 1207 - 1213